CytoVision is proud to announce the official partnership with KFBIO, the world leading digital pathology technology provider. Under this partnership Cytovision will be the sole distributor of KFBio digital pathology and AI technologies in Singapore and Brunei.
As the leader in digital pathology solutions in Malaysia, Cytovision has been at the forefront of whole slide imaging, AI-assisted diagnostics, and telepathology. KFBio, one of the world’s largest and most advanced digital pathology platform provider, brings world-class high-throughput, high-resolution scanning systems and cutting-edge AI solutions to the region.
Together, and in collaboration with our valued partners at Singapore General Hospital, National University Hospital Singapore, and other leading private and public pathology laboratories, this partnership will spearhead end-to-end AI-assisted digital pathology solutions across Southeast Asia.
Our shared mission:
- Deliver faster, more accurate diagnoses
- Streamline pathology workflows with next-generation AI tools
- Transform research and clinical decision-making through advanced digital pathology
This partnership marks a major step towards making digital pathology the new standard of care in the region.
